Literature DB >> 29757551

[Expression and clinical significance of long non-coding RNA LINC00520 in laryngeal squamous cell carcinoma].

Yong Yan Wu1, Wei Gao1, Yu Liang Zhang1, Min Niu1, Jia Jia Cui1, Cai Xia Xiang1, Jiang Wei Sang1, Shu Xin Wen1, Bin Quan Wang1.   

Abstract

Objective:To investigate the expression of LINC00520 in laryngeal squamous cell carcinoma(LSCC),and analyze its relevance and roles in carcinogenesis and development of LSCC.Method:The expression of LINC00520 in laryngeal squamous cell carcinoma tissue and paired adjacent normal tissue was determined by real-time PCR.The relationship between the expression of LINC00520 and the clinicopathological characteristics including clinical stage,pathological type,histological grade and lymph node metastasis of LSCC was analyzed.Result:(1)The LINC00520 expression level was significantly upregulated in LSCC tissues compared to that of paired adjacent normal tissues(P<0.000 1).(2)There were no statistical differences of the LINC00520 expression level among supraglottic,glottic and subglottic LSCCs(P>0.05).The LINC00520 expression level had no significant changes in poorly differentiated LSCC compared with that of well and moderately differentiated counterparts(P>0.05).Moreover,the expression of LINC00520 had no significant difference between T1+T2 stage and T3+T4 stage LSCC tissues(P>0.05).Interestingly,the LINC00520 level in LSCC with lymph node metastasis was significantly higher than that in patients without lymph node metastasis(P<0.01).
Conclusion: Upregulation of LINC00520 in LSCC may contribute to its metastasis.

Entities:  

Keywords:  LINC00520; laryngeal neoplasms; long non-coding RNA; tumor metastasis

Mesh:

Substances:

Year:  2018        PMID: 29757551     DOI: 10.13201/j.issn.1001-1781.2018.02.003

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  6 in total

1.  Long noncoding RNA LINC00520 accelerates lung adenocarcinoma progression via miR-1252-5p/FOXR2 pathway.

Authors:  Xinyue Chen; Huimin Chen; Miaowen Liu; Jianping Xiong; Zhiwang Song
Journal:  Hum Cell       Date:  2021-01-19       Impact factor: 4.174

2.  LncRNA LINC00520 Predicts Poor Prognosis and Promotes Progression of Lung Cancer by Inhibiting MiR-3175 Expression.

Authors:  Gaowei Xia; Xiaoling Li; Fuhui Chen; Zhenyu Shao
Journal:  Cancer Manag Res       Date:  2020-07-17       Impact factor: 3.989

3.  Long noncoding RNA LINC00520 accelerates the progression of colorectal cancer by serving as a competing endogenous RNA of microRNA-577 to increase HSP27 expression.

Authors:  Xi-Han Jin; Yong-Gang Hong; Peng Li; Li-Qiang Hao; Ming Chen
Journal:  Hum Cell       Date:  2020-03-07       Impact factor: 4.174

4.  Characterization of lncRNA LINC00520 and functional polymorphisms associated with breast cancer susceptibility in Chinese Han population.

Authors:  Qiaoyun Guo; Linping Xu; Rui Peng; Yan Ma; Yanli Wang; Feifei Chong; Mengmeng Song; Liping Dai; Chunhua Song
Journal:  Cancer Med       Date:  2020-01-29       Impact factor: 4.452

Review 5.  LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer.

Authors:  Qiudan Zhang; Jinze Shen; Yuchen Wu; Wenjing Ruan; Feng Zhu; Shiwei Duan
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

6.  Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.

Authors:  Wenkang Luan; Yuting Ding; Haitao Yuan; Shaojun Ma; Hongru Ruan; Jinlong Wang; Feng Lu; Xuefeng Bu
Journal:  J Exp Clin Cancer Res       Date:  2020-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.